Fundraising Fox
Ahammune Biosciences
4 known investors
Find your way into Ahammune Biosciences
Sign up to see every warm intro you have to Ahammune Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ahammune Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ahammune develops therapeutic treatments for chronic skin diseases with unmet medical need. The company aims to address dermatological disorders through scientific innovation and comprehensive treatment strategies.
Founders & leadership
DK
Dr. Krishnamurthy Natarajan
DP
Dr. Parul Ganju
Investors · 4
Colossa Ventureslisted by Colossa VenturesMumbai
How we know: Colossa Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Ideaspring Capitallisted by Ideaspring CapitalBengaluru · $2M
How we know: Ideaspring Capital's portfolio page · funding news · press coverage · Not right? Tell us
pi VenturesreportedIndia · $250K – $3M
How we know: funding news · press coverage · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Series AAug 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ahammune Biosciences do?
- Ahammune develops therapeutic treatments for chronic skin diseases with unmet medical need. The company aims to address dermatological disorders through scientific innovation and comprehensive treatment strategies.
- Who founded Ahammune Biosciences?
- Ahammune Biosciences was founded by Dr. Krishnamurthy Natarajan, Dr. Parul Ganju.
- Who are Ahammune Biosciences's investors?
- Ahammune Biosciences's investors include Capital2B, Colossa Ventures, Ideaspring Capital, pi Ventures.